Transcode Therapeutics Inc (RNAZ) — Financial Flexibility Index
Transcode Therapeutics Inc (RNAZ) has a Financial Flexibility Index of -393.72x as of March 2026. Free cash flow of $-4.98 Billion (operating CF $-4.98 Billion minus capex $3.00) represents -394% of total liabilities ($12.64 Million). Check Transcode Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Transcode Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Transcode Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Transcode Therapeutics Inc generate cash.
Annual Financial Flexibility Index for Transcode Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Transcode Therapeutics Inc. Explore Transcode Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.13x | $-19.51 Million | $-19.52 Million | $152.06 Million | ▲ +91.0% |
| 2024 | -1.43x | $-13.31 Million | $-13.34 Million | $9.31 Million | ▲ +72.0% |
| 2023 | -5.11x | $-18.04 Million | $-18.07 Million | $3.53 Million | ▼ -41.9% |
| 2022 | -3.60x | $-15.66 Million | $-15.76 Million | $4.35 Million | ▼ -82.1% |
| 2021 | -1.98x | $-5.01 Million | $-5.27 Million | $2.53 Million | ▼ -3607.0% |
| 2020 | -0.05x | $-238.15K | $-492.97K | $4.46 Million | ▲ +72.4% |
| 2019 | -0.19x | $-253.69K | $-508.51K | $1.31 Million | ▼ -210.0% |
| 2018 | -0.06x | $-44.75K | $-299.57K | $718.61K | — |